Selected research
Industry Growth & Trends
Global Nut Allergy Therapeutics Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Nut Allergy Therapeutics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Nut Allergy Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Nut Allergy Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Nut Allergy Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Nut Allergy Therapeutics market include J & J, HUAPONT Pharm, GSK, Bayer, Viatris, UCB Pharma, Perrigo, Kaleo and Amneal Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Nut Allergy Therapeutics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Nut Allergy Therapeutics market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nut Allergy Therapeutics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nut Allergy Therapeutics.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Nut Allergy Therapeutics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Nut Allergy Therapeutics Market by Company
J & J
HUAPONT Pharm
GSK
Bayer
Viatris
UCB Pharma
Perrigo
Kaleo
Amneal Pharma
ALK Abello
Aimmune Therapeutics
Nut Allergy Therapeutics Segment by Type
Epinephrine Injection
Antihistamines
Other
Nut Allergy Therapeutics Segment by Application
Hospital Pharmacy
Retail Pharmacy
Other
Nut Allergy Therapeutics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nut Allergy Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nut Allergy Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nut Allergy Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Nut Allergy Therapeutics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Epinephrine Injection
- Antihistamines
- Other
Applications
- Hospital Pharmacy
- Retail Pharmacy
- Other
Companies covered
- J & J
- HUAPONT Pharm
- GSK
- Bayer
- Viatris
- UCB Pharma
- Perrigo
- Kaleo
- Amneal Pharma
- ALK Abello
- Aimmune Therapeutics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Nut Allergy Therapeutics Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Nut Allergy Therapeutics Market Size by Region (2021-2032)
- 1.4.1 Global Nut Allergy Therapeutics Market Size by Region (2021-2026)
- 1.4.2 Global Nut Allergy Therapeutics Market Size by Region (2027-2032)
- 1.5 Key Regions Nut Allergy Therapeutics Market Size (2021-2032)
- 1.5.1 North America Nut Allergy Therapeutics Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Nut Allergy Therapeutics Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Nut Allergy Therapeutics Market Size Growth Rate (2021-2032)
- 1.5.4 South America Nut Allergy Therapeutics Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Nut Allergy Therapeutics Market Size Growth Rate (2021-2032)
2 Nut Allergy Therapeutics Market by Type
- 2.1 Type Introduction
- 2.1.1 Epinephrine Injection
- 2.1.2 Antihistamines
- 2.1.3 Other
- 2.2 Global Nut Allergy Therapeutics Market Size by Type
- 2.2.1 Global Nut Allergy Therapeutics Market Size Overview by Type (2021-2032)
- 2.2.2 Global Nut Allergy Therapeutics Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Nut Allergy Therapeutics Market Size Forecasted by Type (2027-2032)
- 2.3 Global Nut Allergy Therapeutics Market Size by Regions
- 2.3.1 North America Nut Allergy Therapeutics Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Nut Allergy Therapeutics Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Nut Allergy Therapeutics Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Nut Allergy Therapeutics Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Nut Allergy Therapeutics Market Size Breakdown by Type (2021-2026)
3 Nut Allergy Therapeutics Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital Pharmacy
- 3.1.2 Retail Pharmacy
- 3.1.3 Other
- 3.2 Global Nut Allergy Therapeutics Market Size by Application
- 3.2.1 Global Nut Allergy Therapeutics Market Size Overview by Application (2021-2032)
- 3.2.2 Global Nut Allergy Therapeutics Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Nut Allergy Therapeutics Market Size Forecasted by Application (2027-2032)
- 3.3 Global Nut Allergy Therapeutics Market Size by Regions
- 3.3.1 North America Nut Allergy Therapeutics Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Nut Allergy Therapeutics Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Nut Allergy Therapeutics Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Nut Allergy Therapeutics Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Nut Allergy Therapeutics Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Nut Allergy Therapeutics Industry Trends
- 4.2 Nut Allergy Therapeutics Industry Drivers
- 4.3 Nut Allergy Therapeutics Industry Opportunities and Challenges
- 4.4 Nut Allergy Therapeutics Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Nut Allergy Therapeutics Revenue (2021-2026)
- 5.2 Global Nut Allergy Therapeutics Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Nut Allergy Therapeutics Key Company Headquarters & Area Served
- 5.4 Global Nut Allergy Therapeutics Company, Product Type & Application
- 5.5 Global Nut Allergy Therapeutics Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Nut Allergy Therapeutics Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Nut Allergy Therapeutics Players Market Share by Revenue in 2025
- 5.6.3 2025 Nut Allergy Therapeutics Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 J & J
- 6.1.1 J & J Company Information
- 6.1.2 J & J Business Overview
- 6.1.3 J & J Nut Allergy Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 J & J Nut Allergy Therapeutics Product Portfolio
- 6.1.5 J & J Recent Developments
- 6.2 HUAPONT Pharm
- 6.2.1 HUAPONT Pharm Company Information
- 6.2.2 HUAPONT Pharm Business Overview
- 6.2.3 HUAPONT Pharm Nut Allergy Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 HUAPONT Pharm Nut Allergy Therapeutics Product Portfolio
- 6.2.5 HUAPONT Pharm Recent Developments
- 6.3 GSK
- 6.3.1 GSK Company Information
- 6.3.2 GSK Business Overview
- 6.3.3 GSK Nut Allergy Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 GSK Nut Allergy Therapeutics Product Portfolio
- 6.3.5 GSK Recent Developments
- 6.4 Bayer
- 6.4.1 Bayer Company Information
- 6.4.2 Bayer Business Overview
- 6.4.3 Bayer Nut Allergy Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Bayer Nut Allergy Therapeutics Product Portfolio
- 6.4.5 Bayer Recent Developments
- 6.5 Viatris
- 6.5.1 Viatris Company Information
- 6.5.2 Viatris Business Overview
- 6.5.3 Viatris Nut Allergy Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Viatris Nut Allergy Therapeutics Product Portfolio
- 6.5.5 Viatris Recent Developments
- 6.6 UCB Pharma
- 6.6.1 UCB Pharma Company Information
- 6.6.2 UCB Pharma Business Overview
- 6.6.3 UCB Pharma Nut Allergy Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 UCB Pharma Nut Allergy Therapeutics Product Portfolio
- 6.6.5 UCB Pharma Recent Developments
- 6.7 Perrigo
- 6.7.1 Perrigo Company Information
- 6.7.2 Perrigo Business Overview
- 6.7.3 Perrigo Nut Allergy Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Perrigo Nut Allergy Therapeutics Product Portfolio
- 6.7.5 Perrigo Recent Developments
- 6.8 Kaleo
- 6.8.1 Kaleo Company Information
- 6.8.2 Kaleo Business Overview
- 6.8.3 Kaleo Nut Allergy Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Kaleo Nut Allergy Therapeutics Product Portfolio
- 6.8.5 Kaleo Recent Developments
- 6.9 Amneal Pharma
- 6.9.1 Amneal Pharma Company Information
- 6.9.2 Amneal Pharma Business Overview
- 6.9.3 Amneal Pharma Nut Allergy Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Amneal Pharma Nut Allergy Therapeutics Product Portfolio
- 6.9.5 Amneal Pharma Recent Developments
- 6.10 ALK Abello
- 6.10.1 ALK Abello Company Information
- 6.10.2 ALK Abello Business Overview
- 6.10.3 ALK Abello Nut Allergy Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 ALK Abello Nut Allergy Therapeutics Product Portfolio
- 6.10.5 ALK Abello Recent Developments
- 6.11 Aimmune Therapeutics
- 6.11.1 Aimmune Therapeutics Company Information
- 6.11.2 Aimmune Therapeutics Business Overview
- 6.11.3 Aimmune Therapeutics Nut Allergy Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Aimmune Therapeutics Nut Allergy Therapeutics Product Portfolio
- 6.11.5 Aimmune Therapeutics Recent Developments
7 North America
- 7.1 North America Nut Allergy Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Nut Allergy Therapeutics Market Size by Country (2021-2026)
- 7.3 North America Nut Allergy Therapeutics Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Nut Allergy Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Nut Allergy Therapeutics Market Size by Country (2021-2026)
- 8.3 Europe Nut Allergy Therapeutics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Nut Allergy Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Nut Allergy Therapeutics Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Nut Allergy Therapeutics Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Nut Allergy Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Nut Allergy Therapeutics Market Size by Country (2021-2026)
- 10.3 South America Nut Allergy Therapeutics Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Nut Allergy Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Nut Allergy Therapeutics Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Nut Allergy Therapeutics Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst